MAPK1 and neoplasm: Several transcriptional signatures associated with the functional activity of the MEK/ERK pathway in various tissues were reported in the literature [17,26,27,28,29], and a 10-gene “MPAS” signature displayed a highly robust MEK inhibition response across multiple tumor types [29].